Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

S Tambone; Mc Fargnoli; Rodolfo Capizzi; Ketty Peris

doi:10.23736/S0392-0488.17.05043-X

Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

S Tambone
, Mc Fargnoli
, Rodolfo Capizzi
, Ketty Peris^*

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

4 Citazioni (Scopus)

Abstract

In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

Lingua originale	Inglese
pagine (da-a)	333-337
Rivista	Giornale Italiano di Dermatologia e Venereologia
Volume	153
Numero di pubblicazione	3
DOI	https://doi.org/10.23736/S0392-0488.17.05043-X
Stato di pubblicazione	Pubblicato - 2018

All Science Journal Classification (ASJC) codes

Dermatologia

Keywords

actinic keratosis

Accesso al documento

10.23736/S0392-0488.17.05043-X

Altri file e collegamenti

Cita questo

@article{a5fe8dddc14840a99be898cfc30c5b23,

title = "Clinical experience of imiquimod 3.75\% for actinic keratosis: results from a case series",

abstract = "In clinical studies, imiquimod 3.75\% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75\% in a real-life clinical setting.",

keywords = "actinic keratosis, actinic keratosis",

author = "S Tambone and Mc Fargnoli and Rodolfo Capizzi and Ketty Peris",

year = "2018",

doi = "10.23736/S0392-0488.17.05043-X",

language = "English",

volume = "153",

pages = "333--337",

journal = "Giornale Italiano di Dermatologia e Venereologia",

issn = "0392-0488",

publisher = "Edizioni Minerva Medica:Corso Bramante 83-85, 10126 Turin Italy:011 39 011 678282318, EMAIL: [email protected], INTERNET: http://www.minervamedica.it, Fax: 011 39 011 674502",

number = "3",

}

TY - JOUR

T1 - Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

AU - Tambone, S

AU - Fargnoli, Mc

AU - Capizzi, Rodolfo

AU - Peris, Ketty

PY - 2018

Y1 - 2018

N2 - In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

AB - In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

KW - actinic keratosis

UR - https://publicatt.unicatt.it/handle/10807/72789

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85047313298&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85047313298&origin=inward

U2 - 10.23736/S0392-0488.17.05043-X

DO - 10.23736/S0392-0488.17.05043-X

M3 - Article

SN - 0392-0488

VL - 153

SP - 333

EP - 337

JO - Giornale Italiano di Dermatologia e Venereologia

JF - Giornale Italiano di Dermatologia e Venereologia

IS - 3

ER -

Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo